Alliance for Cell Therapy Now Commends Congress for Regenerative Medicine and Cell Therapy Provisions in FY 2021 Spending Bill: Additional Support for Clinical Trials for COVID Patients is Still Needed

Alliance for Cell Therapy Now Commends Congress for Regenerative Medicine and Cell Therapy Provisions in FY 2021 Spending Bill: Additional Support for Clinical Trials for COVID Patients is Still Needed

Washington, DC (December 30, 2020) – Leaders of Alliance for Cell Therapy Now (ACT Now)—including representatives of academic and medical institutions, industry innovators, and patients—applaud Congress for its inclusion of important provisions in the final FY 2021...
MESOBLAST UPDATE ON COVID-19 ARDS TRIAL

MESOBLAST UPDATE ON COVID-19 ARDS TRIAL

Melbourne, Australia; December 18, and New York, USA; December 17, 2020: Mesoblast Limited (ASX:MSB; Nasdaq:MESO) today provided an update on the randomized controlled trial of remestemcel-L in ventilator-dependent patients with moderate to severe acute respiratory...

Pin It on Pinterest